Print Friendly, PDF & Email

NCT/Study#

NCT04551885 /

FT516-102

A Phase I, Open-Label, Multicenter Study Of FT516 In Combination With Monoclonal Antibodies In Subjects With Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: